Viridian Therapeutics, Inc. VRDN Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|
| Total revenues by Product | |||||
| Collaboration | $884K+4.1% | $849K+7.6% | $789K+173% | $289K-8.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Viridian Therapeutics, Inc. break its business down?
- Viridian Therapeutics, Inc. (VRDN) reports total revenues by product across 2 parts — Collaboration and License. Each is extracted from the segment footnotes and tracked over time.
- Where does Viridian Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Viridian Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
